Podcasts about GE Healthcare

Send us a textIn the final episode of our Rethinking Phototherapy series, Ben speaks with Steve Falk, Chief Engineer of the Maternal Infant Care Strategic Business Unit at GE Healthcare. With more than three decades of engineering leadership, Steve has been instrumental in the development of landmark neonatal technologies, including the Giraffe Omnibed and Panda platforms.This conversation highlights the critical role of engineering in making phototherapy precise, reliable, and safe. Steve explains how advances in LED technology have transformed phototherapy devices, ensuring consistent irradiance and long product life. He describes how engineers translate clinical needs—wavelength, intensity, surface coverage, and distance—into product requirements, and how rigorous usability testing with clinicians shapes intuitive bedside tools. The discussion also explores innovation on the horizon, from refining intermittent phototherapy strategies to integrating technologies that simplify care and support earlier discharge.Listeners will gain a behind-the-scenes perspective on how engineering teams think about phototherapy as a true pharmacotherapy, and how collaboration between clinicians and industry can directly improve outcomes for newborns and families. This episode closes the series by reminding us that innovation in neonatal care happens not only in clinical practice, but also in the design labs where these essential tools are created.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Trust is the foundation for successfully integrating AI into healthcare systems. In this episode, Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at GE Healthcare, shares how AI is transforming operational efficiency, clinical workflows, and patient outcomes across health systems. He highlights applications such as ambient AI for documentation, AI-driven hospital operations, and unified data infrastructures that ease clinicians' cognitive load. Through GE Healthcare's CareIntellect platform and collaborations with systems like HCA, Duke Health, and Queen's Health, hospitals have achieved measurable improvements, including a 22% boost in patient transfers and $20 million in savings. Dr. Kass-Hout also emphasizes the importance of trust, interoperability, and clinician co-design to ensure AI adoption is ethical, scalable, and effective. Tune in and learn how AI-powered infrastructure and trust-driven innovation are redefining the future of healthcare delivery! Resources Connect with and follow Taha Kass-Hout on LinkedIn. Follow GE Healthcare on LinkedIn and explore their website! Listen to Taha's previous episode on the podcast here Browse the GE Healthcare Research website.

if you have any feedback, please send us a text! Thank you!Dr. J.W. Beard, a UCSF-trained anesthesiologist and Chief Medical Officer of GE Healthcare's Patient Care Solutions division, joins the Vital Times podcast to discuss his remarkable career journey. As a member of the Board of the Anesthesia Patient Safety Foundation, Dr. Beard shares how his background in anesthesiology uniquely prepared him for leadership in the medical technology industry, and offers insights into bridging clinical practice and innovation. 

Max Milz is Group Vice President Connected Technology Solutions at Dentsply Sirona, leading its digital healthcare portfolio, which includes imaging, CAD/CAM, surgical equipment, and AI-based clinical software. A passionate tech leader, he previously spent 12 years at Siemens AG, including five years in China. He serves on the Advisory Board of the Value for Good Foundation and holds degrees from Harvard and Cambridge.   David Ferguson joined Dentsply Sirona as Senior Vice President, Global Business Units in March 2025. David Ferguson is a seasoned executive with extensive leadership experience in the medical device and healthcare industries. He has a strong track record of driving revenue growth, strategic transformation, and operational excellence across multiple global businesses. Most recently, he was President of Gore Medical, a unit of W.L. Gore. Previously, as EVP at Philips and President & CEO of Philips Respironics, he managed a global team of 6,000 people. At Baxter Healthcare, he led the global infusion therapy, IV solutions and patient monitoring business. He also held leadership roles at GE Healthcare. Mr. Ferguson is a Graduate of the Advanced Management Program of University of Chicago Booth School of Business and holds a PhD in Chemistry from Texas A&M University and Bachelor of Science in Biochemistry from David Lipscomb University. He has served on multiple boards, including AZBio, Philips PAC, and Baxter International Foundation, and is a co-inventor of two U.S. patents and author of ten peer-reviewed publications.

In this episode of The Lebanese Physicians Podcast, co-hosts Dr. Khalil Diab and Dr. Hamad Ali sit down with Dr. Firas Mahdi, Partner at LEK Consulting in Singapore, to explore the intersection of strategy, technology, and innovation in healthcare across Asia and the Middle East. From his beginnings in clinical medicine at AUBMC to leadership roles at GE Healthcare, Medtronic, and now LEK, Dr. Mahdi shares a remarkable global journey spanning Lebanon, the Gulf, and Southeast Asia. We discuss: How Singapore's hybrid public–private healthcare model achieves world-class outcomes Lessons for Middle Eastern health systems in value-based care and operational excellence The evolving role of MedTech and AI in shaping the future of healthcare Building purpose-driven careers and navigating non-clinical paths in medicine A rich conversation about healthcare transformation, professional reinvention, and the future of global health strategy — where East truly meets Middle East.  

In this episode of The Dish on Health IT, host Tony Schueth, CEO of Point-of-Care Partners (POCP), is joined by colleagues Brian Dwyer, POCP's Business Strategy Lead, and Seth Joseph, Managing Director at Summit Health Advisors, to unpack their takeaways from the HLTH25 conference in Las Vegas. Together, they reflect on the energy of the event, the conversations shaping the future of health IT, and interviews recorded live from Podcast Row.The trio kicks off by comparing notes on how HLTH has evolved from a flashy innovation show to something more grounded, a space where serious conversations about interoperability, investment, and operational impact are starting to take hold. Seth notes the event's “coming-of-age” moment, where hype gave way to maturity. Brian agrees, adding that the buzz of startups pitching and investors circling was balanced by a sense of realism about implementation and outcomes.AI dominated every conversation, but with a more pragmatic tone than in years past. The hosts discuss how AI is shifting from novelty to necessity, moving from “AI for AI's sake” to purpose-driven use cases. Interview clips from leaders like Taha Kass-Hout with GE Healthcare spotlight “agentic AI,” where autonomous systems could act as trusted colleagues in care delivery, even participating in tumor board decisions to help extend expertise to rural or underserved regions. The group connects this to the ongoing challenge of ensuring data quality and interoperability as the foundation for any AI success story.Laurie McGraw of Transcarent and Kyle Kiser of Arrive Health bring different but complementary perspectives. Laurie underscores AI's potential to bend the cost curve only if applied safely and effectively, while Kyle highlights the growing complexity of affordability and the need for intelligent systems to help patients and providers navigate fragmented benefits and prescription pricing. Seth and Brian note that the shift toward patient empowerment, fueled by AI and transparency, could signal a broader cultural change in healthcare where consumers wield more influence.The discussion expands into value-based care with insights from McKesson's John Beardsley, who questions whether the industry has truly cracked the code after two decades of running at value-based care and interoperability. John also raises an important tension: small innovators are doing exciting things with AI, but scaling those solutions across full workflows remains the real test. The hosts debate whether new payment models, potentially powered by AI-driven insights, could finally make value-based care viable.Policy and regulation also take center stage as Christopher Chen, MD, MBA, Chief Medical Officer at the Washington State Health Care Authority, shares how state and federal efforts are aligning to accelerate interoperability, reduce provider burden, and modernize prior authorization processes under CMS-0057. The hosts reflect on the importance of federal leadership to align incentives across payers, providers, and technology vendors, echoing lessons learned from the early days of ePrescribing.Other memorable interview moments include John Beardsley's commentary on the CMS Interoperability and Patient App Pledges and how better understanding how NCPDP and FHIR standards bridge pharmacy and clinical data silos could help move the needle. Brian and Seth build on that theme, envisioning a future where agentic AI and patient-facing apps work together to drive true engagement and accountability for health outcomes.In the final stretch, the hosts revisit recurring topics such as physician burnout, administrative burden, and structured data chaos, tying them back to the industry's broader need for smarter implementation and aligned incentives. From Christopher Chen's relaying an anecdote about seeing structured data turned into unreadable images that are faxed in to Arrive Health's use of AI to prevent unnecessary transactions, the episode surfaces a consistent theme: technology alone won't fix healthcare, but when paired with aligned incentives, collaboration, and business transformation, it can finally make measurable progress.The episode closes with optimism. Tony, Brian, and Seth agree that while the system is strained, it's also full of momentum, from maturing AI applications to government action and renewed industry alignment. As Tony puts it, “There's a lot to be hopeful about and a lot of work left to do.”Listen to the full episode to hear interviews from the HLTH25 floor, including thought leaders discussing interoperability, agentic AI, and the real-world changes needed to make healthcare innovation stick.Share The Dish on Health IT from Spotify, Apple Podcasts, or Healthcare NOW Radio, Watch extended clips on the POCP YouTube channel

In this episode of the Org Design Podcast, host Tim Brewer and guest cohost Rory Mustan sit down with John Deverill—former British Army lieutenant colonel, ex-GE Healthcare leader, and current NHS change-maker. John shares how the disciplines of military leadership translate into organizational agility, what healthcare can learn from the battlefield, and why most organizations evolve by accident rather than intentional design. From rethinking strategy as “what you actually do,” to building coalitions of the willing, to balancing tradition with innovation, John delivers a masterclass on leading through uncertainty. Whether you're running a hospital, a corporation, or a fast-growing team, this episode will challenge how you think about leadership, strategy, and organizational resilience. John Deverill - https://www.linkedin.com/in/john-deverill-a04a7b1 EODF - https://eodf.eu/ Functionly https://www.linkedin.com/company/functionly https://www.functionly.com/ Org Design Podcast https://www.linkedin.com/company/orgdesignpodcast https://www.functionly.com/org-design-podcast

HR Works Podcast: GE Healthcare on Healing Your People Strategy by HR Daily Advisor

What does it really take to become lean—not just do lean?This is the secret to transformational lean leadership that Larry Culp, CEO of GE and GE Aerospace shared with me on stage three years ago. In this special bonus episode, I want to share his insights and wisdom about leadership and lean culture with you.This bonus episode marks two milestones in my own Chain of Learning® journey: 

In this episode of Let's Combinate: Drugs + Devices, host Subhi Saadeh welcomes Mark Kramer, the founding director of FDA's Office of Combination Products (OCP). Mark takes us on a deep dive into the history of how combination products have been regulated in the U.S., starting with the Safe Medical Devices Act of 1990 and how the process evolved into the formation of OCP in 2002.We explore questions such as: What challenges did industry and the FDA face in the early days of combination products? How did the “Request for Designation” process come about, and how is regulatory identity determined? What is the “Primary Mode of Action” (PMOA) rule and why does it matter? How do user fees, cross-center coordination, and post-market regulations shape how combination products get to market and are monitored? Mark also highlights current regulatory gapssuch as cross-labeling and site registration issues that continue to impact developers.Whether you're working in med-tech, pharma, or regulatory affairs, this episode offers historical perspective, technical insights, and strategic take-aways for navigating the combination-product space. Tune in for a candid conversation with one of the leading figures in this field.Timestamps:00:00 Introduction & Guest Welcome00:35 Historical Background of Combination Products03:05 Creation of Office of Combination Products (OCP)04:29 Early Challenges and Developments04:54 MDUFA, PDUFA, User Fee Programs & Legislative Impact14:24 Defining Primary Mode of Action (PMOA)18:35 OCP's Role & Responsibilities26:49 Industry Adoption & Challenges38:48 Regulatory Gaps & Future Directions46:00 Conclusion & Contact InformationContact & Resources:Connect with Mark Kramer on LinkedIn or via email at Mark.Kramer@greenleafhealth.comMark Kramer is Principal of the Medical Devices & Combination Products regulatory practice at Eliquent Life Sciences (formerly Greenleaf Health). He has more than 35 years experience at FDA and in regulated industry. At FDA, he established and directed the Office of Combination Products and was a scientific reviewer and later supervisor of the premarket review of devices in a variety of medical discipline areas. Following his FDA career, he served as Regulatory Affairs Executive and Chief Regulatory Strategist at GE Healthcare and then as an independent regulatory consultant for over 10 years before joining Greenleaf. Mark served as a board member of the Regulatory Affairs Professionals Society (RAPS) and in 2021, he was awarded the RAPS Founders Award, the profession's highest honor, recognizing exemplary regulatory professionals who have shaped regulatory policy and practice and have made a positive impact on the profession.Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.

Crain's residential real estate reporter Dennis Rodkin joins host Amy Guth to talk news from the local housing market, including Chicago's narrowing lead over U.S. home price growth.Plus: Fed cuts rates quarter point, sets end to balance-sheet runoff, GE HealthCare takes $100 million hit from tariffs, Kraft Heinz lowers sales outlook as CEO warns of worst consumer sentiment in decades and Mondelez also trims outlook, and a developer gets $94 million construction loan for the first phase of its Motorola campus remake.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

market-moving events. The spotlight is on tech with earnings from heavyweights like Microsoft, Google, Meta, and ServiceNow set to hit after the bell. The Fed announcement and Chair Powell's press conference are front and center today, followed by U.S.–China trade talks at tomorrow's APEC Summit. Markets are leaning into a positive narrative—particularly across the tech sector—while energy, healthcare, and materials trail behind. We'll break down the earnings movers, from CAT and GE Healthcare to CVS and Visa, and what all this means for the market's next move.

Die Rallye setzt sich fort, angefacht durch solide Ergebnisse. Außerdem signalisiert Donald Trump, dass die wegen Fentanyl etablierten 20%-Zölle gegen China halbiert oder abgeschafft werden dürften. Trump betont ebenfalls, dass in den Gesprächen mit Xi auch NVIDIA ein Thema sein wird. An der Wall Street werden die Ziele für die Aktie weiter angehoben, unter anderem von der Bank of America und der UBS. Mit der Bewertung nun bei bereits $5 Billionen, betont CEO Jensen Huang, dass es sich in dem Sektor um keine Spekulationsblase handeln soll. Die Ergebnisse aus dem Tech-Sektor fallen seit gestern Abend solide aus, mit robusten Zahlen von SK Hynix, Seagate, Teradyne und Bloom. Nach dem Closing melden Google, Meta und Microsoft Ergebnisse. Man wird sich vor allem auf die Capex-Investitionen fokussieren. Auch außerhalb des Tech-Sektors fallen die Zahlen robust aus, mit den Aktien von Booking Holdings, CVS Health, Caterpillar, GE Healthcare, und Verizon teils stärker im Plus. Visa und Mondelez stehen nach den Quartalszahlen leicht unter Druck. Etsy verliert rund 10% vor Handelsstart. Dort wird unter anderem der CEO ausgetauscht. Um 20 Uhr MEZ wird die US-Notenbank den Leitzins um 25 Basispunkte senken. Die Wall Street vermutet, dass auch das Ende des Abbaus der Bilanz gemeldet wird. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Die Rallye setzt sich fort, angefacht durch solide Ergebnisse. Außerdem signalisiert Donald Trump, dass die wegen Fentanyl etablierten 20%-Zölle gegen China halbiert oder abgeschafft werden dürften. Trump betont ebenfalls, dass in den Gesprächen mit Xi auch NVIDIA ein Thema sein wird. An der Wall Street werden die Ziele für die Aktie weiter angehoben, unter anderem von der Bank of America und der UBS. Mit der Bewertung nun bei bereits $5 Billionen, betont CEO Jensen Huang, dass es sich in dem Sektor um keine Spekulationsblase handeln soll. Die Ergebnisse aus dem Tech-Sektor fallen seit gestern Abend solide aus, mit robusten Zahlen von SK Hynix, Seagate, Teradyne und Bloom. Nach dem Closing melden Google, Meta und Microsoft Ergebnisse. Man wird sich vor allem auf die Capex-Investitionen fokussieren. Auch außerhalb des Tech-Sektors fallen die Zahlen robust aus, mit den Aktien von Booking Holdings, CVS Health, Caterpillar, GE Healthcare, und Verizon teils stärker im Plus. Visa und Mondelez stehen nach den Quartalszahlen leicht unter Druck. Etsy verliert rund 10% vor Handelsstart. Dort wird unter anderem der CEO ausgetauscht. Um 20 Uhr MEZ wird die US-Notenbank den Leitzins um 25 Basispunkte senken. Die Wall Street vermutet, dass auch das Ende des Abbaus der Bilanz gemeldet wird. Ein Podcast - featured by Handelsblatt. +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ +++ Hinweis zur Werbeplatzierung von Meta: https://backend.ad-alliance.de/fileadmin/Transparency_Notice/Meta_DMAJ_TTPA_Transparency_Notice_-_Ad_Alliance_approved.pdf +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html Impressum: https://www.360wallstreet.de/impressum

In this episode, Hemish was joined by Karin von Hodenberg, VP of Quality at Monte Rosa Therapeutics.Karin has repeatedly built quality systems from the ground up across med device and biotech, and she translates that experience into practical, phase-appropriate guidance for early teams.Karin's journey is anything but typical: a business background, supply chain and Lean Six Sigma Black Belt training led her into quality at GE Healthcare and Philips, before moving into biotech with bluebird bio during rapid growth. She's since led in several startups and now at Monte Rosa, where she's implemented validated systems early and embedded a genuine culture of quality across GxP.She talks about the following:Why a non-traditional path (business → supply chain → Six Sigma) can be a superpower in Quality.From paper to validated eQMS: how bluebird bio migrated training & documents and why they verified 100% of records.Trigger points for moving beyond paper: signs you're outgrowing a doc control room and how to stand up DMS/LMS/LIMS early.Phase-appropriate, risk-based thinking: using data, science and regulations - without becoming a blocker.Making quality ‘cool': education, storytelling, and visible sponsorship from ELT.Leading without fear: replacing “inspection readiness day” with “inspection readiness every day.”Critical thinking over checkbox compliance: hiring, interview questions, and building the muscle across teams.Working with functional heads: cadence of 1:1s, being a partner (not a gate), and influencing through solutions.Roadmaps that breathe: Karin's 3‑year plan, quarterly outcomes, and how transparency sustains engagement in uncertainty.AI pragmatism in quality: where note-taking and drafting help now - and where human judgment still rules.Karin is a thoughtful, pragmatic Quality leader who balances compliance with business value - bringing people with her as she builds systems that last.Thank you Karin for sharing your incredible journey.Hope everyone enjoys the show!

In this episode, Jan Beger, Global Head of AI Advocacy at GE Healthcare, shares his mission to bridge the gap between the conceptual promise and real-world impact of AI in healthcare. He stresses on the critical need to build AI literacy and trust among clinicians, executives, and students, and explains why a human-centric approach and strong change management are critical for successful adoption. Jan highlights GE's global AI literacy programs that train employees and clinicians on responsible use, practical applications, and critical evaluation of AI. He highlights how moving beyond pilots to strategic, systemwide deployment requires continuous education, executive engagement, and a focus on change management. He also spoke about GE's successes such as improved efficiency in software development and innovations like AI-guided handheld ultrasound devices that democratize imaging by supporting users of varied expertise, as well as the challenges of keeping AI tools robust and up-to-date. Jan addresses the future of the workforce, noting that adaptability and tech fluency will be essential as 70% of job skills evolve by 2030. He encourages healthcare leaders to see AI not just as technology, but as a transformative tool to enhance care and outcomes. Take a listen.

India has long held its position as the “pharmacy of the world” and a global biotech hub. And now, another revolution is unfolding in medical technology with India aiming to become a $30 billion MedTech manufacturing powerhouse by 2030. Leading this from the forefront is Wipro GE Healthcare, which is building products not just for India but also for the world. The company has 1200+ patents and is revolutionising healthcare by improving accessibility and affordability. With 4 world-class manufacturing sites, listen in to know how it is contributing towards India's sunrise sector - MedTech.

In this episode of the WLEI Podcast, we speak with Eric Ethington and Matt Zayko about how to build strong teams and robust product and process development systems, and why doing so takes a skilled chief engineer. Eric Ethington is a senior coach and Chief Engineer, Lean Product and Process Development (LPPD) at The Lean Enterprise Institute. Matt Zayko is global head of the Lean Office at GE HealthCare. Eric and Matt are also coauthors of the book, The Power of Process: A Story of Innovative Lean Process Development.   The conversation explores:   The key skills every chief engineer needs to be effective and “lead with responsibility, not authority”   How chief engineers can begin the work of “designing the value stream”  Why conflict is necessary to create good products and how to manage conflict with care   System integration and how chief engineers optimize work at the product level, balancing the inputs and needs of product development and manufacturing, for example  Real stories of product and process development where Eric and Matt have seen teams persevere and use LPPD thinking to innovate and achieve success     Read Eric and Matt's article “9 Tips to Better Process Development” here.    Get Started with Lean Product & Process Development  Improving how you develop and deliver products doesn't require a full transformation to start—it begins with learning to see problems clearly, involve your team, and improve how work gets done.  Explore your next step:  Read Designing the Future or The Power of Process  Take the 60-minute Lean Product and Process Development Overview course  Join the coach-led online Designing the Future Workshop for hands-on practice, and the in-person Introduction to Lean Process Development course Oct 7  Bring a coach into your organization for customized support  Let's take the first step—together. Learn more at lean.org/LPPD » 

In dieser Folge spricht Dr. Kerstin Stachel mit Prof. Dr. Jörg F. Debatin, einem der profiliertesten Köpfe des deutschen Gesundheitswesens. Der Radiologe war Direktor des Universitätsklinikums Hamburg-Eppendorf, später CEO des UKE, Vice President von GE Healthcare und Leiter des Health Innovation Hub des Bundesgesundheitsministeriums unter Jens Spahn. Heute ist er Gründer von mehreren Unternehmen, berät zahlreiche Start-ups und hat mehreren Aufsichtsratsmandate.Im Gespräch geht es um die zentralen Herausforderungen des Gesundheitswesens:​den demografischen Wandel und die wachsende Versorgungslücke,​warum es nicht zu wenige Ärzt:innen, sondern ineffiziente Strukturen gibt,​Digitalisierung als Effizienztreiber – und warum Führung & Wille entscheidend sind,​Krankenhausreform, regionale Versorgung und die Rolle der Telemedizin,​warum Führungskompetenz und Kommunikation über harte Zahlen hinaus der Schlüssel zum Erfolg sind.Eine inspirierende Folge für alle, die sich für die Zukunft von Krankenhäusern, Digitalisierung und Gesundheitspolitik interessieren.​​Folgt HealthCareBrain bei Spotify in dem ihr die Glocke aktiviert und unterstützt uns doch mit einer Bewertung.

Dr. Linda Chu speaks with Dr. Andrew Trout, Professor of Radiology and Director of Clinical Research at Cincinnati Children's, and Dr. Erin Angel, Vice President of Research and Scientific Affairs at GE HealthCare. They discuss the unique challenges of pediatric imaging and how collaboration and technology are advancing care for young patients while improving imaging for all. Sponsored by GE HealthCare.

In this episode of the HR Leaders Podcast, we speak with Adam Holton, Chief People Officer at GE HealthCare, about the mindset shifts HR leaders need to harness AI, personalize learning, and lead with authenticity. Adam explains why example matters more than instruction, why democratized learning is changing leadership, and how AI can act like a “superpower” for HR teams. The conversation covers embedding AI into coaching, rethinking processes instead of just automating them, and creating sticky adoption through daily use cases.

Get the book!The greatest innovations often begin with a simple question: "What if we tried this differently?" In this fascinating exploration of innovation mindsets, we unpack the two complementary approaches that fuel breakthroughs—design thinking and first principles thinking.hese very approaches are at the heart of my book Protection for the Inventive Mind, a practical fieldbook that helps inventors and creatives turn frustrations into prototypes and big ideas into protected strategies.From the Wright brothers' wind tunnel experiments at Kitty Hawk to SpaceX landing rockets upright, we trace how returning to fundamental truths allows inventors to rebuild solutions from scratch. These stories show first principles thinking as the "logic scalpel" that cuts through assumptions and tradition to reveal new possibilities.Alongside this analytical approach, we discover design thinking—the "empathy engine" that powers human-centered innovation. We see how watching an arthritic woman struggle with kitchen tools birthed OXO Good Grips, how children's tears transformed hospital MRI machines into pirate ships, and how PillPack revolutionized medication management by truly understanding patient frustrations.The episode reveals surprising connections between seemingly unrelated innovations. The kingfisher bird's perfect dive inspired Japan's bullet train nose design. Velcro emerged when a Swiss engineer examined burrs stuck to his dog under a microscope. These moments of biomimicry demonstrate how nature offers solutions to our most persistent challenges.What's particularly inspiring is how often world-changing ideas emerge from everyday annoyances—James Dyson's 5,000 vacuum prototypes, IKEA's flat-pack revelation from a stubborn table that wouldn't fit in a car, and Airbnb's humble beginnings with air mattresses on an apartment floor. These stories prove that frustration can be billion-dollar inspiration when viewed through the right lens.Ready to apply these mindsets to your own challenges? Listen for five actionable innovation principles distilled from these remarkable stories, and discover how combining empathy with fundamental thinking can transform not just products, but experiences, systems, and culture itself. Whether you're sketching on a napkin or aiming for the stars, the way you think might be your greatest invention yet.Send us a textSupport the show

What does it take to build intelligent systems that are not only AI-powered but also secure, scalable, and grounded in real-world needs? In this episode of Tech Talks Daily, I speak with Srinivas Chippagiri, a senior technology leader and author of Building Intelligent Systems with AI and Cloud Technologies. With over a decade of experience spanning Wipro, GE Healthcare, Siemens, and now Tableau at Salesforce, Srinivas offers a practical view into how AI and cloud infrastructure are evolving together. We explore how AI is changing cloud-native development through predictive maintenance, automated DevOps pipelines, and developer co-pilots. But this is not just about technology. Srinivas highlights why responsible AI needs to be part of every system design, sharing examples from his own research into anomaly detection, fuzzy logic, and explainable models that support trust in regulated industries. The conversation also covers the rise of hybrid and edge computing, the real challenges of data fragmentation and compute costs, and how teams are adapting with new skills like prompt engineering and model observability. Srinivas gives a thoughtful view on what ethical AI deployment looks like in practice, from bias audits to AI governance boards. For those looking to break into this space, his advice is refreshingly clear. Start with small, end-to-end projects. Learn by doing. Contribute to open-source communities. And stay curious. Whether you're scaling AI systems, building a career in cloud tech, or just trying to keep pace with fast-moving trends, this episode offers a grounded and insightful guide to where things are heading next. Srinivas's book is available on Amazon under Building Intelligent Systems with AI and Cloud Technologies, and you can connect with him on LinkedIn to continue the conversation.

Send us a textJoin us for an in-depth conversation with Bryant Foster, a human factors expert who's worked with industry giants like Google to make complex products simpler and safer. With a background in cognitive psychology, Bryant shares insights on designing user-friendly products, from surgical systems to smart thermostats, all while keeping the end user at the center of the design process.Main Topics:What drew Bryant into human factors and user experience designHow to define and achieve simplicity in product designAdvanced usability testing tools: eye tracking, pupilometry, and facial emotion analysisWhy users don't always give honest feedback and how to work around itProviding critical design feedback without demoralizing teamsCost-effective approaches to human factors testingSafety considerations in medical device designUse-related risk analysis and task analysis methodologiesLessons learned from working at Google XBuilding successful human factors consulting teamsAbout the guest: Bryant Foster is the Vice President of Human Factors and User Experience at Research Collective, a user-centered research consultancy serving clients from startups to major companies like GE Healthcare, Microsoft, and Medtronic. With over a decade of experience in applied psychology and usability research, he specializes in ensuring products are safe, intuitive, and user-focused.He holds a Master's in Applied Psychology (Human Factors) from Arizona State University and began his career at the Cognitive Engineering Research Institute, later working at Google X as a UX researcher. At Research Collective in Tempe, Arizona, he leads a team that uses methods like ethnography, eye tracking, and biometric analysis.In addition to his consulting work, Bryant mentors students and supports local entrepreneurs through programs like LEAP, blending scientific rigor with empathy in fields from medical devices to consumer tech.Links:Bryant Foster LinkedInResearch Collective WebsiteClick here to learn more about simulation solutions from Simutech Group.

In this industry sponsored episode, host Praveen Ranganath speaks with Dr. Seth Uretsky from Morristown Medical Center about the growth of their multimodality cardiac imaging program. Tune in and enjoy!This episode is sponsored by GE HealthCare.References to a specific product, process, or service by speakers in this podcast episode do not constitute or imply an endorsement by the Society of Cardiovascular Computed Tomography. The views and opinions expressed in do not necessarily reflect those of the Society of Cardiovascular Computed Tomography.

In this episode, we explore how nonprofit organizations like LBDA are working alongside industry partners to shape the evolving landscape of dementia biomarkers—bridging scientific innovation with real-world care. Featuring an engaging conversation with Dr. Sudhir Sivakumaran, Dr. Kathleen Poston, and Dr. Dustin Dunham on clinical utility, patient-centered research, and the road to broader adoption of biomarkers in Lewy body dementia, Alzheimer's disease and related disorders. This episode is sponsored by GE HealthCare

US Treasury Secretary Bessent said he will see US President Trump regarding the China tariff pause on Wednesday and some technical details remain on the China tariff pause, while the China tariff extension decision will be up to Trump and if he does not approve tariff pause extension, tariffs on Chinese goods would 'boomerang' back to April 2nd levels, or another level that he chooses.US President Trump said Chinese President Xi wants to meet and he thinks it will happen before the end of the year, while he stated that they will either approve the trade extension or not. Chinese Vice Commerce Minister Li said the US and China have agreed to extend the trade truce; Bessent said China jumped the gun a little on the 90-day pause.Crude futures surged yesterday amid comments from US President Trump who confirmed changing the deadline for Russia to reach a Ukraine ceasefire agreement to 10 days, while there were simultaneous comments from Treasury Secretary Bessent who told Chinese officials that China could face high tariffs if it continues to purchase sanctioned Russian oil due to US secondary tariff legislation.APAC stocks traded mixed following the subdued handover from Wall St; European equity futures indicate a mildly positive cash market open with Euro Stoxx 50 futures up 0.3% after the cash market closed with gains of 0.8% on Tuesday.Looking ahead, highlights include French GDP, Spanish CPI, German GDP & Retail Sales, Italian GDP, ECB Wage Tracker, EZ GDP & Sentiment, US ADP National Employment, GDP Advance (Q2), PCE (Q2), Fed, BoC, BCB Policy Announcements Speakers including Fed Chair Powell, BoC's Macklem & Rogers, Supply from Italy, US Quarterly Treasury Refunding Announcement.Earnings from Hermes, Airbus, Vinci, Danone, Capgemini, HSBC, GSK, Aston Martin, Santander, Caixabank, Telefonica, Intesa Sanpaolo, Leonardo, Mercedes Benz, Siemens Healthineers, BASF, Adidas, Porsche AG, Meta, Microsoft, RobinHood, Carvana, Lam Research, Qualcomm, Ford, Arm, eBay, FMC, Vertiv, Altria, Kraft Heinz, GE Healthcare & VF Corp.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

European bourses are mixed amidst a slew of earnings, US futures flat/firmer ahead of a busy data docket and earnings from Meta and Microsoft.USD rally pauses for breath as markets await Q2 flash GDP and FOMC.USTs contained into numerous US events, Bunds were little moved by national and EZ-wide GDP metrics.Crude takes a breather after Tuesday's rally while gold holds around the unchanged mark.Looking ahead, US ADP National Employment, GDP Advance (Q2), PCE (Q2), Fed, BoC, BCB Policy Announcements Speakers including Fed Chair Powell, BoC's Macklem & Rogers. US Quarterly Treasury Refunding Announcement.Earnings from Airbus, Vinci, Microsoft, RobinHood, Carvana, Lam Research, Qualcomm, Ford, Arm, eBay, FMC, Vertiv, Altria, Kraft Heinz, GE Healthcare.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

U.S. stocks are hitting all-time highs, but can the rally continue? According to Adam Johnson, portfolio manager of the Bullseye American Ingenuity Fund, the answer is a resounding yes. In this high-energy interview, Adam makes the bullish case for American innovation, explains why AI is the most transformative force of our time, and names the companies poised to dominate the next decade. From autonomous trucking and warehouse robotics to Tesla's humanoid factory workers, Adam reveals the real-world AI applications already disrupting industries—and how investors can position for it. He also shares how he manages risk, takes profits, and navigates volatility in a market full of mixed signals.

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Cristian: Curiosity and passion.The danger of radiation exposure has always been a concern in medical imaging, especially in surgeries requiring 3D visualization. Cristian Atria, Founder & CEO of nView medical, has tackled this challenge head-on with groundbreaking technology that reduces radiation exposure while improving surgical outcomes.In this interview, Cristian explained how nView's innovative surgical scanner allows surgeons to see in 3D during operations, creating images in seconds without the risks associated with traditional imaging methods like CT scans. “We've created a new way to create images very fast in 3D,” Cristian shared. “The surgeon has the benefit of having 3D visualization, which leads to more accurate surgeries without the cost of having to radiate the patient.”This cutting-edge technology is already making an impact, particularly in pediatric surgeries. Cristian emphasized the importance of protecting children, who are especially vulnerable to radiation, while ensuring surgeons have the tools they need for complex procedures. “We decided to start in pediatrics first because it's the population that requires more protection with respect to radiation,” he explained.What makes this innovation even more compelling is that it isn't just a prototype or a distant dream. nView's devices are already being used clinically, and the company is now raising capital via a regulated crowdfunding campaign on StartEngine. This campaign provides an opportunity for ordinary investors to support—and benefit from—this life-changing technology.Cristian's work highlights the potential of innovation to improve not just health outcomes, but also the quality of care for vulnerable populations. By reducing risks and enhancing surgical precision, nView medical is reshaping the future of healthcare.For those intrigued by the potential of this technology, the crowdfunding campaign offers a chance to be part of this transformative journey. As Cristian noted, “This is a technology we've developed over the last 10 years, and it's already being used clinically.”This is exactly the kind of innovation that deserves attention and support.tl;dr:Cristian Atria's nView medical developed technology for fast, low-radiation 3D imaging during surgeries.The technology improves surgical precision, especially in pediatric procedures, reducing risks for vulnerable patients.nView's devices are commercially available, and the company is raising funds via StartEngine crowdfunding.Cristian's superpower, curiosity and passion, drives his success in solving complex problems innovatively.A personal story of saving his son's life illustrates the power of persistence and asking questions.How to Develop Curiosity and Passion As a SuperpowerDuring today's episode, Cristian revealed his superpower: a boundless curiosity paired with a passion for connecting disparate ideas. “One minute in my everyday work, I can be thinking about medical physics. The other minute, I'm thinking about a surgical application or talking to a surgeon,” he explained. This ability to explore, connect, and apply knowledge across domains has fueled his success at nView medical and beyond.Cristian shared a deeply personal story about his twin sons, who were born prematurely. When one faced worsening health issues, Cristian's curiosity and persistence led to a breakthrough. By asking the right questions and engaging with clinicians, he realized his son's diagnosis was incorrect. This discovery shifted the treatment plan, ultimately saving his son's life. The experience underscored Cristian's belief in the power of curiosity and dialogue to solve complex problems.Tips for Developing This Superpower:Ask Questions: Never hesitate to ask questions, even in unfamiliar or intimidating situations.Engage with Experts: Sit down with people in different fields to learn about their work and challenges.Embrace Failure: Don't fear asking “silly” questions—curiosity often leads to unexpected insights.Leave Your Comfort Zone: Step beyond your area of expertise to explore new ideas and perspectives.Be Persistent: Keep seeking answers and connections until you find solutions.By following Cristian's example and advice, you can make curiosity and passion a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileCristian Atria (he/him):Founder & CEO, nView medicalAbout nView medical: nView medical is a Delaware, with headquarters in Salt Lake City, Utah. It is a medical technology company specializing in real-time 3D imaging solutions for spine, orthopedic, and surgical applications. By integrating advanced imaging hardware and AI-powered software, nView medical aims to enhance surgical accuracy, optimize workflows, and improve patient outcomes. The company's main product, the FDA-cleared nView s1 system, provides hospitals with an innovative imaging solution to help surgeons perform surgeries more accurately, while reducing the amount of radiation needed for imaging. Currently, nView medical is commercializing specifically in the market of pediatric spine and orthopedic surgery and has top pediatric hospitals as customers.Website: nviewmed.comX/Twitter Handle: @nviewmedical Company Facebook Page: facebook.com/profile.php?id=61575887188366Other URL: startengine.com/offering/nviewmedicalBiographical Information: A healthcare entrepreneur with over 20 years of experience in product development and commercialization. Previously at GE Healthcare, he led major platform launches. Cristian holds multiple patents and advanced degrees in engineering and business. Cristian Atria was born in Santiago, Chile.Personal Facebook Profile: facebook.com/cristian.atria.professionalInstagram Handle: @thedopple Linkedin: linkedin.com/in/catriacSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, Rancho Affordable Housing (Proactive), and Emerald PH. Learn more about advertising with us here.Max-Impact MembersThe following Max-Impact Members provide valuable financial support:Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear |  Matthew Mead, Hempitecture |  Michael Pratt, Qnetic | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Ralf Mandt, Next Pitch | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on August 19, 2025, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, August 20, 2025, at 12:00 PM Eastern. Devin Thorpe, CEO and Founder of The Super Crowd, Inc., will lead a session on "Your Portal, Your Future: How to Choose the Right Reg CF Platform." With so many investment crowdfunding portals available today, selecting the right one can be overwhelming for both founders and investors. In this session, Devin will break down the critical factors to consider—such as platform fees, audience demographics, compliance support, industry focus, and overall user experience. Whether you're a founder planning a raise or an investor exploring where to put your dollars to work, you'll walk away with a clearer understanding of how to evaluate and choose the platform that best aligns with your goals. Don't miss this practical, insight-packed hour designed to help you take your next step in the Reg CF ecosystem with confidence.SuperCrowd25, August 21st and 22nd: This two-day virtual event is an annual tradition but with big upgrades for 2025! We'll be streaming live across the web and on TV via e360tv. Apply for the Live Pitch here. VIPs get access to our better-than-in-person networking, including backstage passes, VIP networking and an exclusive VIP webinar! Get your VIP access for just $25. A select group of affordable sponsorship opportunities is still available. Learn more here.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Devin Thorpe is featured in a free virtual masterclass series hosted by Irina Portnova titled Break Free, Elevate Your Money Mindset & Call In Overflow, focused on transforming your relationship with money through personal stories and practical insights. June 8-21, 2025.Join Dorian Dickinson, founder & CEO of FundingHope, for Startup.com's monthly crowdfunding workshop, where he'll dive into strategies for successfully raising capital through investment crowdfunding. June 24 at noon Eastern.Future Forward Summit: San Francisco, Wednesday, June 25 · 3:30 - 8:30 pm PDT.Regulated Investment Crowdfunding Summit 2025, Crowdfunding Professional Association, Washington DC, October 21-22, 2025.Impact Accelerator Summit is a live in-person event taking place in Austin, Texas, from October 23–25, 2025. This exclusive gathering brings together 100 heart-centered, conscious entrepreneurs generating $1M+ in revenue with 20–30 family offices and venture funds actively seeking to invest in world-changing businesses. Referred by Michael Dash, participants can expect an inspiring, high-impact experience focused on capital connection, growth, and global impact.Call for community action:Please show your support for a tax credit for investments made via Regulation Crowdfunding, benefiting both the investors and the small businesses that receive the investments. Learn more here.If you would like to submit an event for us to share with the 9,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

A set of AI use cases within the medical space. David Meier, Asit Sharma, and Roland Rott discuss: The latest on GE Healthcare, of which GE Healthcare Imaging is a piece. How AI is used to create efficiency gains, AND How AI is used to boost patient outcomes. Hosts: David Meier and Asit Sharma Guest: Roland Rott Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Lauren Kim is joined by Parminder Bhatia, Chief AI Officer, and Roland Rott, President and CEO of GE HealthCare Imaging, to explore how artificial intelligence is reshaping medical imaging. They discuss the potential of AI to improve efficiency, enhance diagnostic accuracy, and address key challenges like workforce shortages and rising demand for care.  This episode is sponsored by GE HealthCare. 

The Trump administration's federal cuts that have gutted grants threaten the work of Illinois researchers. Crain's contributor Judith Crown talks with host Amy Guth about the potential long-term impacts of such funding cuts.Plus: Gov. Pritzker to announce he's running for a third term; Ronald McDonald House buys neighboring Streeterville property and eyes expansion; GE HealthCare and Stanford Medicine renew partnership to push total body scanning tech; and McDonald's and Krispy Kreme end partnership over cost issues.

On this industry-sponsored episode, host Praveen Ranganath, MD continues the "Building a Cardiac CT Program" series through a conversation with David Furman, MD the cardiothoracic imaging division director at St. Lukes University Health Network in Pennsylvania. Topics include platforming CT upgrades, complex imaging reimbursement landscapes, and the halo effect of cardiac CT. Tune in and enjoy!This episode is sponsored by GE Healthcare.References to a specific product, process, or service by speakers in this podcast episode do not constitute or imply an endorsement by the Society of Cardiovascular Computed Tomography. The views and opinions expressed in do not necessarily reflect those of the Society of Cardiovascular Computed Tomography.

Shannon Watts is the founder of Moms Demand Action, a prominent grassroots organization fighting gun violence in the United States. She initially aspired to be an investigative journalist, and she earned a journalism degree but transitioned into a career in public relations, spending nearly two decades in corporate communications at companies like Anthem and GE Healthcare. After taking a step back from her career to become a stay-at-home mom, the Sandy Hook tragedy in 2012 spurred her into action, and she founded Moms Demand Action with a simple Facebook group. Leveraging her communications and branding expertise, she transformed the group into a powerful nationwide movement, now part of Everytown for Gun Safety, the largest gun violence prevention organization in the country, with nearly 11 million supporters. She has since been recognized as one of Time's 100 Most Influential People and a Forbes 50 Over 50 Changemaker. She's also authored books including Fight Like a Mother and Fired Up.Buy Shannon's new book here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode of The Medical Alley Podcast, we welcome Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at GE HealthCare. With a combination of clinical insight and technology experience, Dr. Kass-Hout has a uniquely expert perspective on AI's impact in the healthcare arena. Dr. Kass-Hout talks about how GE Healthcare is embedding AI into clinical workflows, the improvement of patient care, the reduction of clinical burden, and more. Send us a message! Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.

In this episode, HR Daily Advisor Content Director Erika Randall chatted it up with Tyrese Manigault, Manager of Employee Engagement at NASCAR, at SPARK HR 2025, about creative ways to engage employees—whether they're new and onboarding or seasoned and looking for career pathways. Manigault shares how NASCAR engagement initiatives are meeting employees where they are and engaging them in a modern and creative way. Learn also about NASCAR's peer recognition program that's embedded in this top-ranked motorsports organization of the world! Did you miss SPARK HR this spring? Not to worry! Join us live in San Antonio at SPARK TALENT 2025 and get practical strategies focusing on workforce planning, talent acquisition, and AI-driven processes! Discover proven solutions from top HR thought leaders from PepsiCo, Walmart, Staples, The Coca-Cola Company, Marriott, and GE HealthCare, and get ready to adapt your talent strategy for the future.

Preena: Welcome to the Weinberg in the World Podcast, where we bring stories of interdisciplinary thinking in today's complex world. My name is Preena Shroff and I'm your student host of this special Weinberg in the World episode. I'm a third year student majoring in neuroscience and global health studies with a minor in data center. Today I have the pleasure of speaking with Natasha Phillips, who graduated from Weinberg College in 2000 with a Bachelor of Arts in sociology and biology. Natasha currently serves as chief marketing officer for GE Healthcare, leading teams that help healthcare providers design treatment plans for their patients. Natasha, thank you so much for being here with us today. Natasha: Thanks for having me, Preena. It's a pleasure. Preena: We are so excited to learn about your work in healthcare marketing, but would love to start out with how your career path was shaped by your time at Northwestern. Maybe you can tell us more about your undergraduate experience, what were some impactful classes, extracurriculars, or mentorships opportunities that you had which impacted your post-graduate career? Natasha: Yeah. You're making me think a little bit, because I got to go back in time. As an undergraduate, I was super lucky, having both a biology and a sociology major, it gave me the ability to see a very wide range of classes. I wasn't 100% sure actually what I wanted to do. I knew I was somewhat interested in the sciences. I didn't actually know I would be that interested in the social sciences, but I took a couple of classes. One in particular was the Sociology of Race and Ethnicity with Charlie Moskos, which actually made me decide to ... That was the reason I became a sociology major. I just got super lucky, I loved that class. It's funny, if I ever had a second life, I always say I would have loved to have gone back and been a sociology professor. But I didn't take that path, I went more with the actual biology side of things. I was weighing, do I want to do research? I actually was really interested in molecular biology, primarily because in the late '90s, which is a very long time ago to our students who are listening, but for me that was a time very formative because they were sequencing the human genome. There was a lot of promise in the space, not only of biology, but more specifically molecular biology and how it is linked to genetics and genomics as we think about the impact on healthcare. That really interested me to the point where I really was considering actually getting my PhD in molecular biology. Some of my favorite classes were the ones in which I had exposure to research, because I got to see the importance of just the impact that research can have. And the ability to be able to find a practical application, even if it's on a very specific question, to really contribute to the body of knowledge. Ultimately ended up being unsure what I wanted to do right after undergrad, so I went into healthcare consulting in which I wanted to be able to figure out, do I want to go towards the more business side of healthcare and thinking about commercializing healthcare and science from the industry side of things? Or to the academic side and actually get my PhD, and think about contributing to science and healthcare in that realm. I did have exposure, both in consulting as well as in research. I started in a research program at the University of Chicago in molecular biology after doing consulting so I could see both sides. And ultimately, actually, that was when I made the decision to focus much more so on the business side of it and to get my MBA, and to move into healthcare marketing. That led me into the career in which I've had today, in which I've been very lucky to have over 15 years working at very large multinational healthcare companies, primarily in sales and marketing roles, bringing innovation in healthcare to people all over the globe. Preena: Absolutely. Wow, yeah. I think your path is actually not only a common path that students seek out, but also something that students might end up finding themselves in, even if they do experience a career switch in their life. That's really interesting to hear about. I have another question for you, more specifically job-oriented. Healthcare is constantly evolving, so maybe you can tell us a little bit about how your marketing approach has changed since you began your career? Natasha: Yeah. I love that question, Preena, because what really is happening is healthcare is evolving and the function of marketing is evolving constantly. I am really lucky that, both in the subject matter that I basically have decided to focus in, which is healthcare and ultimately the innovation around healthcare, but also have a really cool and exciting function that continues to evolve. I was lucky enough during my ... Maybe I'll start with the functional part, I'll start with marketing first, and then I'll talk about healthcare. The basic function of marketing has changed significantly over the past 20 years as I've been a marketer, primarily with the advent of digital and social media. It continues now to evolve, as we think about personalized marketing and AI, and what that's going to do. I would say the main changes that I've seen over time has been from a very I would say structured, one size fits all, if you think about it like mass media type of marketing in which there was a time in which you had one singular message and one singular way of approaching individuals, and not a lot of channels to reach them. To now, moving to almost a fully personalized marketing experience, where you have the ability with technology today to be able to say, even if you have thousands of targets, how do you understand the fine differences. There's got to be some generalization amongst those targets, but there's also some fine differences in how people consume their information, care about interacting with your brand, and want to be able to either become loyal brand advocates or detractors. How do you understand what those insights are to create an ongoing personalized journey that evolves over time with the individual as their media consumption and interest in whatever product you're selling changes? That's been one of the coolest innovations to think about, as we think about the function. If I look at healthcare, I've been lucky enough to see innovation across a variety of different segments within healthcare. I'd seen the advent of biologics. If we think about innovation from a healthcare point of view, in basically the last 20 years or so, we've seen drugs like Humira, which started the biologic class and has now exploded into one of the largest categories or segments within healthcare. And the significant impact that that has had on millions of patients, and has changed diseases all the way from skin conditions to much more serious autoimmune type of conditions. I've been lucky enough to see innovation on the diagnostic side, in which I've seen the advent of brand new technologies, including things like multi-plexing. Of taking a single sample, and instead of wanting to get one answer, you can get anywhere from 25 to 30 answers of which virus of which disease somebody has. And the impact that that has had not only on just healthcare, but on infectious disease and vaccines in other parts. For me, what has actually kept me so motivated in healthcare for so long is it isn't just an idea. I get to be part of the teams, and it's a cross-functional team that includes everybody from scientists, research and developers, operations, medical affairs, clinical affairs, marketers, salespeople, finance people, and everybody, I'm sure I'm forgetting some functions. It is such a complex effort to bring innovation like this to market and sometimes can take 10 to 15 years, but when it happens you actually see significant change in healthcare. For me, that's the ability to think even 30, 40 years from now, some of the either diagnostics, devices, or drugs that I've helped to bring to market will really have an impact. Either because it continues to improve healthcare or it was the precursor of future innovation that's going to continue to come because we've paved the way for it, so it's really cool. Preena: Absolutely. That's really incredible. And the way you're able to work with people of many different fields and backgrounds, and then learn from them as well is a really incredible experience, and I hope defines a lot of students' careers in the future as well. Natasha: Yeah. I think just to add to that, the one thing to really keep in mind is I love the interdisciplinary approach that a really good college in arts and sciences like Weinberg does. Because for me, that kind of thinking, although I didn't understand it at the time because I was just a student and I had no clue what I was actually going to do, is something that to this day in my career I think back to and I leverage. It's helped to make me successful, especially in a very large matrix cross-functional organization. It's something that, as all of you who are students potentially listening to this and are thinking, "What might I do in the future?" Really leverage the opportunities that you have to do that kind of interdisciplinary type of work because it will make you much stronger in whatever field you decide to do. Preena: Yeah, absolutely. Going off of that, a bit in the other direction, but what is a common misconception about working in the healthcare marketing industry? Natasha: That is a great question. This is maybe a little controversial, but I'm going to say it. I think there is this perception of big, bad pharma and big, bad healthcare. I think it's something that is an understandable point of view and one which requires probably much more dialogue than what we can answer here. But I'll just leave people with this one thought. Which is if you think about most of the major innovations that have come to healthcare over the last 30 years, whether it's drugs to treat high blood pressure or hypertension, or innovations in diagnostics as I mentioned to be able to not just understand what's happening from blood count, but to be able to look at the molecular and cellular level to treat rare diseases and everything in the middle. Much of that innovation, while it is funded and founded in the basic research that happens at academic and other institutions, has really been driven by the industry. Whether it's the pharmaceutical industry, the med device industry, the diagnostic industry. That requires significant investment and significant time. It also requires a very high failure rate. In some cases, if you have 100 compounds or 100 ideas that you're bringing through, less than 1% of them will sometimes make it to market. There is a significant amount of investment that needs to happen. While there's always optimizations that could happen, I always implore people to think about the fact that the drug that your mother or father is taking today, or that your brother or sister is taking for asthma, didn't exist probably even 20 or 30 years ago because we didn't have the funding and innovation that was coming necessarily maybe from companies that has been pushing that forward. While there is a lot of discussion to be had about healthcare and the rights to healthcare, I think companies like mine, whether it's my current company or previous company, have played a very important role in really helping to improve overall health and healthcare as we think about the impact on people's lives. I just ask people to be open to the fact that there's always a variety of different vantage points and it's always a great healthy dialogue to have. Preena: Of course, yeah. From what you said, it sounds like it's a bit of a trade-off and it's really important to discover where you fit in within that sphere, and learn how to interpret your work and your path in that direction as well. Just realizing what impact you're making and picturing that longterm. Natasha: Yeah, exactly. Preena: Okay. Then, I was also going to ask you about the student perspective, thinking about students today. How would you recommend students cultivate a personal brand? A lot of times people say networking. How do students network authentically, both online and in-person so that they can find the right opportunities or even the right opportunities can find them? Natasha: Yeah, I think it's a really great question. I very much will reiterate the importance of networking because I think that's foundational and fundamental to everything that we do today. In fact, many of you who got into very competitive colleges probably had to figure that out as you were even thinking about how to get into the school that you're in today. That thought process needs to continue as you think about getting your first job, or maybe you're getting your next pre-professional school that you're focused on. I would take that networking to the next step to say I think some of the most effective networking has two really good components. I find this, because I have a lot of people who maybe reach out to me, either through my network or because they're looking for learning about marketing or healthcare, or other topics that maybe I've had some experience with. The first of those two things is really having a genuine brand, and one in which you really own and feel passionate about. The most interesting and coolest networking that I do, even with students today, are the ones in which people are very purposeful about what they are interested in, what they care about, what their brand is. It's probably hard to even think about me as a college student, what is my brand? But you have a brand. You may not know it yet, but you definitely have and can develop a brand. That brand should be whatever you feel truly passionate and genuinely interested in, because that will only I would say help you have much more successful networking and much more genuine connections with the people that you are trying to connect with. Even if that individual maybe doesn't understand or isn't that maybe close to the topic, you'd be shocked how just that genuine authenticity is going to help drive really stronger connections in networking that are going to help both you, as well as the network that you're creating, as you think about the fact that one day you're going to have a network and you're going to want to be able to pay it forward to students the way maybe people are helping you with your decisions and career today. The second one as you think about networking is a lot of times, networking and finding a good fit, whether it's a company or your next pre-professional program, or what you even want to do, is based on having a shared purpose with whoever you're networking with or whatever that institution is. I find the people who come and are most prepared for interviews, in addition to feeling very genuine and knowing what their brand is, are the people who are very clear on what my purpose, either as an institution is, or whatever group I'm part of. They understand that and it is very much akin to who they are, what they're looking for, what makes them passionate. That sense of shared purpose in networking I think is another way in which you can more successfully think about how do you take your decisions or whatever you're going to do next in your career path and be more successful in terms of what you want to do. Then the last thing I would say is don't feel super ... I know everybody's pressured to feel like they know exactly what they want to do and I understand that. I'm sure many of the people who are listening to this are very high performing, have always been very successful in life, have known exactly what they want to do. But there's a lot of benefit to maybe giving yourself the luxury of knowing you have a very long marathon ahead of you, as you think about the decision making in your career choices that you're going to make. If there's ever a time to be open to it, it's probably earlier in your career when you're maybe more willing to not only take some risks, but also be true to what you actually think will be interesting to you over a longterm career. Don't be afraid if it's not going to be a straight line. It might be a really curvy, cool path. At the time, it might feel a little discouraging, but don't be discouraged. Because I would argue, if I look back, some of my coolest decisions were the ones in which it wasn't this straight line, very clear path of what I wanted to do. But rather, I was either more open because of external circumstances or internal motivation to being a little bit more flexible and not so purposeful, and everything must be this in this timeframe. I think if you have some openness to that, it will really help you and probably put a lot less pressure on you as you're thinking about your career. Preena: Right. Yeah, that's really great advice. In terms of winding paths, switching over to your career and more of your day-to-day role, what would say is a challenge or challenges that you often find or encounter in your day-to-day role and how do you approach those? Natasha: That's a good question. My challenges in my day-to-day role. I'm fortunate in which I lead a functional team, so I have the benefit of having an amazing team that I work with every day across a variety of brands and products, across a very diverse portfolio. I've been lucky enough to do that at this current company, which is GE Healthcare, and the previous company I was at which is Abbott. Many times, if I think about the biggest challenges in my day-to-day, it really is around I would say three big areas. The first one is when you are such a large matrix company that is so dependent on your other functional teams, to ensure that you are all very clear on what the goal is, what you're all trying to accomplish, and that you're all rowing in the same direction, and have shared purpose and goals. Often times in our day-to-day, even in companies where you think everybody's on the same team, you can often find that there's actually sometimes a bit of misalignment or competing priorities. Sometimes that's because we're different functions or groups, sometimes it's because we're different segments. Sometimes it's just because we don't understand that shared goal. It's keeping everybody aligned to the mission, strategy, and vision. I would say as marketers actually, I feel like we are big drivers of that in an organization. It's something I always feel very responsible for and want to help my team feel very responsible for. That's the first one. The second one is we work in a very complex landscape. We're highly regulated here in healthcare. We want to do the right thing. Actually, I always tell people I'm so glad that we're highly regulated because the decisions we make actually impact life or death. It's actually for all the right reasons that we have very strict regulatory and approval processes, and then ongoing monitoring of all of our activities from our quality processes to our commercial processes and everything in between. But that can bring a lot of complexity. You've got to navigate a lot of sometimes tough legal and compliance discussions. But at the end of the day, the way we navigate them successfully as a team is really by reminding ourselves that the reason these regulations exist is to keep patients, our own family members who are consuming healthcare every day safe. We're able to do that. I feel we, despite sometimes difficult discussions, always get to the best answer in doing what's right for the patient and what's right for healthcare. Then the third thing, which is I think sometimes hard, is we all come to work every day because we actually care about healthcare and saving lives. That's sometimes really hard to remember when you get stuck in your day-to-day. You can be at a tough meeting, or a really hard strategy review, or a really hard finance review, or maybe you're missing your number in this sales goal. But at the end of the day, those hard days are really worth it because of what ultimately we're bringing to patients all over the globe. Again, there are these challenges, but over a long career I've been able to figure out how to successfully navigate them. So that I feel that even the challenges motivate me to come to work, and figure it out, and be better tomorrow. Better today and tomorrow than I was yesterday and in the past. I try to motivate my teams to think about that in the same way. Preena: Absolutely. Oh, yeah, that was very insightful. I think a lot of these can be applied to any fields, because a lot of times, in healthcare specifically, there is definitely life and death impacts. Then in other fields, people can have those same hard conversations and still need to have that resilience and build up that resilience to come back from that. Natasha: Very true. Very, very true. Probably very similar, just maybe different categories, but very similar discussions that would happen- Preena: Absolutely. Natasha: ... outside of healthcare, too. Preena: Yeah. Okay. Well, thank you very much for sharing this with us and thank you for joining us today. That is all the questions I have. We really value your time, and for coming on and speaking to all of our students. Thank you very much. Natasha: Thank you for having me. It was pleasure to talk to you.  

Host Justin Barnes recorded live at HIMSS25 in Las Vegas. Stay tuned for the next few weeks to hear all his guests. This week his guest is Simon Rost, Chief Marketing Officer at GE HealthCare. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Wine, flamingos, and a glass box…this is NOT your typical BILIH episode...Amit and Jeff join you from the ASRA Spring Annual Meeting 2025 in Orlando, Florida, where they recorded live interviews with over a dozen influential thinkers in regional anesthesiology. Join us as we chat and laugh with James Kim, Sandy Kopp and Nadia Hernandez over discussions of POCUS, probe covers, catheters, the NEW anticoagulation guidelines, and much much more!

Send us a textOn this ABM Done Right Podcast episode, Eric Gruber sits down with Jodie Lail (Revenue Marketing Leader at GE Healthcare) to discuss why teams need a revenue marketing organization if they are engaging in ABM. Eric also digs into the GE Healthcare ABM program and discusses what's working for them - and where there are opportunities to have a stronger revenue impact. 

In this episode, HR Daily Advisor Content Director Erika Randall catches up with the delightful Ben Eubanks, author and Chief Research Officer at Lighthouse Research & Advisory, at SPARK HR 2025 in Disney Springs. Eubanks' research includes surveying thousands of workers each year to understand the latest workplace trends. In this podcast, Randall and Eubanks have a lively chat about Eubanks' books, the workshops he led at SPARK, and how to help HR leaders solve workplace issues using “innovation sprints.” Eubanks' books include: Artificial Intelligence for HR: Use AI to Support and Develop a Successful Workforce Talent Scarcity: How to Hire and Retain a Shrinking Workforce Payroll Promise: Trust, Not Just Transactions Did you miss SPARK HR this spring? Not to worry! Join us live in San Antonio at SPARK TALENT 2025 and get practical strategies focusing on workforce planning, talent acquisition, and AI-driven processes! Discover proven solutions from top HR thought leaders from PepsiCo, Walmart, Staples, The Coca-Cola Company, Marriott, and GE HealthCare, and get ready to adapt your talent strategy for the future.

US equity futures are pointing to a higher open today. European markets are firmer, following notable strength in Asian markets. Global markets influenced by China Commerce Ministry's remark that Beijing is evaluating the US offer on trade negotiations, which signals China's openness to discussions. The softened tone now is being seen as a latest de-escalation signal following recent reports that Beijing has quietly exempted certain US-made goods from tariffs. Japan also aims to achieve a trade agreement with the US in June, though the country has suggested that treasury holdings are among cards it may use in talks.Companies mentioned: Viper Energy, GE HealthCare, Johnson & Johnson, Medtronic, JetBlue Airways

US President Trump said he is going to make a fair deal with China on trade; predicts that China will eat the tariffs.APAC stocks failed to sustain the positive handover from Wall St and traded mixed; Chinese official PMIs disappointed.European equity futures indicate a contained cash market open with Euro Stoxx 50 future flat after the cash market closed with losses of 0.2% on Tuesday.DXY is a touch higher and building on yesterday's slight gains, EUR/USD is back on a 1.13 handle, AUD leads post-CPI.Looking ahead, highlights include French GDP, German Import Prices, Retail Sales, Unemployment Rate, GDP, CPI, Italian GDP, CPI, EZ GDP, US ADP, GDP, PCE (Q1 & for March), ECI, BoC Minutes, BoE's Lombardelli, Supply from UK, Germany & US.Earnings from Microsoft, Meta, Robinhood, Qualcomm, Albemarle, eBay, Humana, Caterpillar, International Paper, GE Healthcare, Hess, Airbus, Credit Agricole, TotalEnergies, SocGen, UBS, DHL, Kion, Volkswagen, Mercedes Benz, Barclays, GSK, Segro & Glencore.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

US President Trump said he is going to make a fair deal with China on trade; predicts that China will eat the tariffs.Stocks trade tentatively ahead of a slew of key risk events, including US GDP/PCE and earnings from Microsoft & Meta.USD looks to build on Tuesday's advances, EUR overlooks strong GDP, AUD is supported by hot CPI.USTs are contained into data & refunding, EGBs firmer but largely unaffected by a data deluge.Subdued trade across industrial commodities amid uncertainty and overall downbeat Chinese PMIs.Looking ahead, US ADP, GDP, PCE (Q1 & for March), ECI, BoC Minutes, Comments from BoE's Lombardelli, US Quarterly Refunding.Earnings from, Microsoft, Meta, Robinhood, Qualcomm, Albemarle, eBay, Humana, Caterpillar, International Paper, GE Healthcare, Hess.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10 What do you think about the leadership? 23:44 Let's talk about sustainability. Tell us about the medical device industry's collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59 Let's talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53 Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20 Preview of episode 33 39:27 Give us your feedback 40:23 Team Mah-rvel: the Party for a Purpose 40:41 Thanks 40:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA). Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch.  Das Buch zum Podcast? Jetzt lesen.  China revanchiert sich. Boeing, GE Healthcare, Apple, IPOs & Banken leiden. Adidas, Nike & Lululemon freut das Vietnam-Gespräch von Trump. Musk will keine Zölle. Hershey kauft Millionen-Popcorn, Microsoft feiert 50sten, Honda kann Space & Bitcoin ist stabil. Ein zyklisches Business in wirtschaftlich unsicheren Zeiten ist keine gute Kombo. Thyssenkrupp (WKN: 750000) steigt trotzdem. Der Grund: Rüstung, Infrastruktur und die Hoffnung auf Frieden. Von den 18 reichsten Menschen der Welt haben nur 2 dieses Jahr Rendite gemacht: Warren Buffett & Carlos Slim. Den ersten kennt ihr. Der zweite ist der John D. Rockefeller Mexikos mit América Móvil (WKN: A3D8PK), Grupo Carso (WKN: 885075) & Inbursa (WKN: 900573) Diesen Podcast vom 07.04.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com GE Healthcare is leading the way in global medical technology and pharmaceutical diagnostics by leveraging innovations like AI and cloud computing to reduce healthcare disparities and improve access. In this episode of The Beat Podcast, Dr. Taha Kass-Hout, GE Healthcare's Global Chief Science and Technology Officer, discusses how GE Healthcare is leading in global medical technology and pharmaceutical diagnostics through innovations like AI and cloud computing to reduce healthcare disparities and improve access. He introduces the AI-driven CareIntellect platform for oncology and the Health Companion project, which uses agentic AI to optimize patient treatment plans. Dr. Kass-Hout also explains how these technologies can alleviate clinician burnout by streamlining workflows and enhancing operational efficiencies, and highlights GE Healthcare's AI Lab initiative focused on mammography screening. Tune in to gain valuable insights into how GE Healthcare is driving innovation and transforming the future of healthcare. Resources: Connect with and follow Dr. Taha Kass-Hout on LinkedIn. Follow GE Healthcare on LinkedIn and visit their website. Fast Track Your Business Growth: Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

Are you ready optimize your team's performance and efficiency? In this podcast hosted by Mark Bailes, GE Healthcare Technical Product Lead Erica Ahn will be speaking on the art and science of organizational design. Drawing from her extensive experience at GE Healthcare, Erica shares insights on how to strategically structure teams, manage change, and drive business outcomes through thoughtful organizational approaches.

In this special live episode, with guests Lisa Christensen, Hillary Miller and Christopher Lind, we explore their experience and deep expertise on the topics of L&D strategy and team structures - and it’s a masterclass of a conversation. Register for L&D Next 3rd - 6th March for free today at https://360learning.com/l-and-d-next/2025/ KEY TAKEAWAYS Understand what L&D is there to achieve. Team structures have to evolve and be flexible. L&D structure has to be right for achieving L&D aims, so it may be different from other teams in the organisation. Build adaptable teams by focusing on skillsets. Leverage data and hone in on one KPI. Understand which relationships and functions you need to focus on. That will evolve. Work holistically with other areas of the business. BEST MOMENTS “I've never seen a truly centralized model, ever.” “We can get hung up on the hierarchy of things and miss out.” “You gotta know who your players are, their bench strengths.” “We need better data capabilities in learning.” “Figure out what they care about and then lean on that.” Lisa Christensen Lisa leads McKinsey & Company's Learning Design and Development Center of Excellence, a global team of design experts, designing and building the learning that develops McKinsey Partners and professionals, enabling them to deliver incredible client impact. Lisa founded and leads McKinsey's Learning Research and Innovation Lab and sits on the global learning leadership team. https://www.linkedin.com/in/lisachristensen Christopher Lind Christopher Lind is a dynamic leader at the intersection of business, technology, and human experience, serving as an executive advisor, AI ethicist and sought-after voice in the L&D space. As a former Chief Learning Officer for ChenMed and GE Healthcare, Christopher has led transformative learning strategies that enhance workforce capability and business performance. A prominent commentator, speaker, and thought leader, he is known for his forward-thinking approach to digital learning, AI, and the evolving role of technology in talent development. https://www.linkedin.com/in/christopherlind Future Focused: https://christopherlind.substack.com Hillary Miller Hillary Miller is a seasoned Learning & Development leader currently heading L&D at HCA Healthcare. With a passion for driving workforce capability and business impact, she brings extensive experience in healthcare education and leadership development. Previously, as Chief Learning Officer at Penn State Health, Hillary led enterprise-wide learning strategies, fostering a culture of continuous development and innovation. https://www.linkedin.com/in/hillarybmiller VALUABLE RESOURCES https://podcasts.apple.com/gb/podcast/the-learning-development-podcast/id1466927523 L&D Master Class Series: https://360learning.com/blog/l-and-d-masterclass-home THE HOST David James David has been a People Development professional for more than 20 years, most notably as Director of Talent, Learning & OD for The Walt Disney Company across Europe, the Middle East & Africa. As well as being the Chief Learning Officer at 360Learning, David is a prominent writer and speaker on topics around modern and digital L&D. CONTACT METHOD Twitter:  https://twitter.com/davidinlearning LinkedIn: https://www.linkedin.com/in/davidjameslinkedin L&D Collective: https://360learning.com/the-l-and-d-collective Blog: https://360learning.com/blog L&D Master Class Series: https://360learning.com/blog/l-and-d-masterclass-home